HARVONI

Pharmaceuticals, namely, antivirals; anti-inflammatories; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the prevention and treatment of hepatitis and HIV/AIDS; anti-infectives